Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Yubo International Biotech Ltd | yubo_10q.htm |
| EX-32.1 - EX-32.1 - Yubo International Biotech Ltd | yubo_ex321.htm |
| EX-31.2 - EX-31.2 - Yubo International Biotech Ltd | yubo_ex312.htm |
| EX-31.1 - EX-31.1 - Yubo International Biotech Ltd | yubo_ex311.htm |
EXHIBIT 32.2:
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Quarterly report on Form 10-Q of Yubo International Biotech Limited for the quarter ended November 30, 2020, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
|
| (1) | such Quarterly report on Form 10-Q for the quarter ended November 30, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
|
| (2) | the information contained in such Quarterly report on Form 10-Q for the quarter ended November 30, 2020 fairly presents, in all material respects, the financial condition and results of operations of Yubo International Biotech Limited. |
| January 19, 2021 | /s/ Liu Lina | ||
|
|
| Name: Liu Lina, |
|
|
|
| Chief Financial Officer |
|